From the Center for Genomic Medicine (S.M., J.C., J.Q.A.H., J.R., C.D.A.), Department of Neurology (J.R., C.D.A.), and Henry and Allison McCance Center for Brain Health (J.R., C.D.A.), Massachusetts General Hospital, Boston; Institute for Stroke and Dementia Research (M.K.G., M.D., R.M.), University Hospital of Ludwig-Maximilians-University; Graduate School for Systemic Neurosciences (M.K.G.), Ludwig-Maximilians-University, Munich, Germany; Department of Medicine (Biomedical Genetics) (J.C.), Boston University School of Medicine, MA; Munich Cluster for Systems Neurology (SyNergy) (M.D.); German Centre for Neurodegenerative Diseases (DZNE) (M.D.), Munich, Germany; and Program in Medical and Population Genetics (J.R., C.D.A.), Broad Institute of Harvard and MIT, Cambridge, MA.
Neurology. 2020 Jun 16;94(24):e2581-e2591. doi: 10.1212/WNL.0000000000009642. Epub 2020 May 21.
Leveraging large-scale genetic data, we aimed to identify shared pathogenic mechanisms and causal relationships between impaired kidney function and cerebrovascular disease phenotypes.
We used summary statistics from genome-wide association studies (GWAS) of kidney function traits (chronic kidney disease diagnosis, estimated glomerular filtration rate [eGFR], and urinary albumin-to-creatinine ratio [UACR]) and cerebrovascular disease phenotypes (ischemic stroke and its subtypes, intracerebral hemorrhage [ICH], and white matter hyperintensities [WMH] on brain MRI). We (1) tested the genetic overlap between them with polygenic risk scores (PRS), (2) searched for common pleiotropic loci with pairwise GWAS analyses, and (3) explored causal associations by employing 2-sample Mendelian randomization.
A PRS for lower eGFR was associated with higher large artery stroke (LAS) risk ( = 1 × 10). Multiple pleiotropic loci were identified between kidney function traits and cerebrovascular disease phenotypes, with 12q24 associated with eGFR and both LAS and small vessel stroke (SVS), and 2q33 associated with UACR and both SVS and WMH. Mendelian randomization revealed associations of both lower eGFR (odds ratio [OR] per 1-log decrement, 2.10; 95% confidence interval [CI], 1.38-3.21) and higher UACR (OR per 1-log increment, 2.35; 95% CI, 1.12-4.94) with a higher risk of LAS, as well as between higher UACR and higher risk of ICH.
Impaired kidney function, as assessed by decreased eGFR and increased UACR, may be causally involved in the pathogenesis of LAS. Increased UACR, previously proposed as a marker of systemic small vessel disease, is involved in ICH risk and shares a genetic risk factor at 2q33 with manifestations of cerebral small vessel disease.
利用大规模遗传数据,我们旨在确定肾功能障碍与脑血管疾病表型之间的共同致病机制和因果关系。
我们使用了肾功能指标(慢性肾脏病诊断、肾小球滤过率估计[eGFR]和尿白蛋白与肌酐比值[UACR])和脑血管疾病表型(缺血性卒中及其亚型、脑出血[ICH]和脑 MRI 上的脑白质高信号[WMH])的全基因组关联研究(GWAS)的汇总统计数据。我们(1)使用多基因风险评分(PRS)测试它们之间的遗传重叠,(2)通过两两 GWAS 分析搜索常见的多效性位点,(3)通过两样本孟德尔随机化探索因果关系。
较低的 eGFR 的 PRS 与较高的大动脉卒中(LAS)风险相关( = 1 × 10)。在肾功能指标和脑血管疾病表型之间发现了多个多效性位点,12q24 与 eGFR 和 LAS 及小血管卒中(SVS)相关,2q33 与 UACR 和 SVS 及 WMH 相关。孟德尔随机化显示,较低的 eGFR(每降低 1-log 的比值比[OR],2.10;95%置信区间[CI],1.38-3.21)和较高的 UACR(每增加 1-log 的比值比[OR],2.35;95% CI,1.12-4.94)均与 LAS 风险增加相关,以及较高的 UACR 与较高的 ICH 风险相关。
通过降低 eGFR 和增加 UACR 评估的肾功能障碍可能与 LAS 的发病机制有关。UACR 升高,以前被提出作为全身小血管疾病的标志物,与 ICH 风险有关,并与 2q33 处的脑小血管疾病表现共享遗传风险因素。